Clinical Trials Sponsored by Kellogg Company

Total 6051 results

Kowa Company, Ltd.

Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Kowa Company, Ltd.

Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Dyslipidemias

Japan
The Medicines Company

Completed

Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) (ORION-9)

Elevated Cholesterol | Heterozygous Familial Hypercholesterolemia

United States, Canada, Czechia, Denmark, Netherlands, South Africa, Spain, Sweden
The Medicines Company

Completed

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol (ORION-10)

Elevated Cholesterol | ASCVD

United States
RAI Services Company

Completed

CSD190401: A Study to Assess Elements of Abuse Liability for Nicotine-containing Pouch Tobacco Products

Smoking | Tobacco Use | Tobacco Smoking | Smoking Behaviors

United States
Taiwan Liposome Company

Completed

A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

Hallux Valgus

United States
RAI Services Company

Completed

CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products

Smoking | Tobacco Use | Tobacco Smoking

United States
The Medicines Company

Completed

Cangrelor to Clopidogrel or Prasugrel Transition Study (BRIDGE)

Coronary Artery Disease (CAD)

United States
BrainScope Company, Inc.

Completed

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes (AheadCAS-HS)

Brain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, Intermediate

United States
The Medicines Company

Completed

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

Renal Impairment

New Zealand
Taiwan Liposome Company

Terminated

A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Taiwan
The Medicines Company

Completed

Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation (AMPHORE)

Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

France
The Medicines Company

Completed

Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy (ABP-700)

Colonoscopy

Netherlands
The Mentholatum Company

Completed

Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye

Dry Eye | Dry Eye Syndromes

United States
Lannett Company, Inc.

Completed

Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia

Any Ear Nose or Throat Conditions | With Identified Need for a Diagnostic Procedure or Surgery on or Through the Mucous Membranes of the Nasal Cavities

United States
Lannett Company, Inc.

Terminated

Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia

Diagnostic | Procedures and Surgeries on or Through Accessible Mucous Membranes | of the Nasal Cavities

United States
The Medicines Company

Completed

Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH (BRAVO 2/3)

Transcatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic Stenosis

Netherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
BrainScope Company, Inc.

Completed

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department (READ-TBI)

Brain Injuries

United States
The Medicines Company

Completed

European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial (EUROMAX)

Acute Coronary Syndrome

Denmark, Netherlands, Italy, France, Germany, Poland, Austria, Czech Republic, Slovenia
The Medicines Company

Completed

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE) (ACCELERATE)

Hypertension | Hemorrhage

United States, Germany
Lorillard Tobacco Company

Completed

Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes

Smoking

United States
The Medicines Company

Terminated

A Clinical Trial to Demonstrate the Efficacy of Cangrelor (PCI)

Myocardial Infarction (MI) | Acute Coronary Syndromes (ACS)

United States
The Medicines Company

Completed

Maintenance of Platelet Inhibition With Cangrelor (Bridge)

Acute Coronary Syndrome (ACS)

United States
Mundipharma Medical Company

Completed

Morphine Slow-release Capsules in Substitution Therapy

Opiate Dependent

Switzerland
Baylis Medical Company

Completed

Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty

Lower Back Pain

United States
BioBehavioral Diagnostics Company

Completed

Adult Normative Performance of the Quotient ADHD System (ADHD)

ADHD

United States
The Medicines Company

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

Cardiopulmonary Bypass | Coronary Artery Bypass Graft
BrainScope Company, Inc.

Terminated

Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury

Brain Injuries | Craniocerebral Trauma

United Kingdom
The Medicines Company

Completed

Utilisation of Angiox® in European Practice (EURO-vision)

Stable Angina (SA) | NSTE-ACS (NSTEMI and UA) | STEMI (STE-ACS)

France, Germany
The Medicines Company

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

Healthy

United States
The Boeing Company

Completed

Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort

Acute Mountain Sickness
QuatRx Pharmaceuticals Company

Completed

Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis

Psoriasis

United States
The Medicines Company

Completed

Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI

Myocardial Infarction

United States
Xuanwu Hospital, Beijing
Beijing Mario Biotech Company; Hebei Senlang BIotech Company; Beijing HuiNengAn...

Recruiting

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Glioma | Malignant Glioma of Brain | Recurrence Tumor

China
R.J. Reynolds Vapor Company
RAI Services Company; Davita Clinical Research

Completed

Comparison of Pharmacokinetic Parameters Between Adopters of Electronic Cigarettes and a Historical Sample of Combustible Cigarette Smokers

Smoking

United States
Eli Lilly and Company

Not yet recruiting

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity | Weight Gain

United States, Taiwan, Australia, France, Germany, Canada, United Kingdom, Spain, Israel, Argentina, Mexico, Puerto Rico
Becton, Dickinson and Company

Not yet recruiting

Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product

Blood Culture of Microorganisms
Eli Lilly and Company

Not yet recruiting

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Glioma

United States
Eli Lilly and Company

Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
Eli Lilly and Company

Recruiting

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Healthy

United States
Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers

Healthy

Korea, Republic of
Eli Lilly and Company

Recruiting

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Belgium, Italy, United States, Bulgaria
Eli Lilly and Company

Not yet recruiting

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Alzheimer Disease

United States, United Kingdom, Japan
Eli Lilly and Company

Recruiting

A Study of LY3841136 in Japanese Participants With Obesity or Overweight

Obesity | Overweight

Japan
Eli Lilly and Company

Recruiting

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy | Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Recruiting

A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors

Advanced Solid Tumors

China
Hanmi Pharmaceutical Company Limited

Recruiting

Dose Escalation and Expansion Study of BH3120 in Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Korea, Republic of, United States
Eli Lilly and Company

Recruiting

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

United States
Eli Lilly and Company

Recruiting

A First-In-Human Study of LY3839840 in Healthy Participants

Healthy

United States
Eli Lilly and Company

Recruiting

A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Obesity | Overweight

United States

Clinical Trials Sponsored by Kellogg Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations